First class

tossing mortarboards

Pharmacists in the opening round of Advancing Practice have been notified of their credentials

This marks the end of Round 1 2018 evaluations and a new milestone for the growing pharmacy leadership program.

The completion of Round 1 saw 34 applicants from around the country and a variety of practice settings credentialed as either Stage I Advancing Practice, Stage II Advancing Practice or as an Advanced Practice Pharmacist, conferring the postnominals AdvPP(I), AdvPP(II) and Adv. Prac. Pharm., respectively.

Deirdre Criddle, Chair of Pharmacy Development Australia, the independent body which awarded the final credentials, says the detailed portfolio reports provide robust feedback through which pharmacists can build on their practice, influence and impact.

“The Advancing Practice Advisory Board has overseen the development of a robust process that will provide this ‘first class’ of pharmacists with objective assessment of how they can best guide their future development, ensuring they are responding to the evolving needs of patients and the healthcare sector,” she said.

“The implications for Australian pharmacists are internationally significant – the Advancing Practice program aligns with FIP’s 2015 Advanced Practice and Specialisation in Pharmacy global report and 2016 Pharmaceutical Workforce Development Goal 4: Advanced and Specialist Development.”

The portfolio evaluation reports evaluated practitioners’ impact on pharmacy practice and patient care against each competency level, and each domain, within the Advanced Pharmacy Practice Framework, developed by the Pharmacy Practitioner Development Committee.

Associate Professor Ian Coombes, Chair of the Advisory Board says the strong response to the program shows Australian pharmacists, from a wide array of practice, are enthusiastic about engaging in a formal process of independent evaluation of their portfolio, receiving feedback and recognition.

“By facilitating independent evaluation, Advancing Practice provides an objective mechanism through which any pharmacist – regardless of their scope of practice and healthcare setting – can determine their impact on patient care, medicines management and on the practice of their fellow pharmacists and other healthcare professionals,” he said.

“Ultimately, the process assures Australians and fellow healthcare professionals that improving outcomes for patients is front and centre to all pharmacists’ practice.”

Previous $50k fine and costs after ‘shocking’ unlawful advertising
Next Clinical tips: antimicrobial resistance

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.